(AI) C3 Ai - Overview
Sector: Technology | Industry: Software - Infrastructure | Exchange: NYSE (USA) | Market Cap: 1.515m USD | Total Return: -59.7% in 12m
Avg Turnover: 46.8M
Qual. Beats: 0
Rev. Trend: 22.5%
Qual. Beats: 0
Warnings
Altman Z'' -1.89 < 1.0 - financial distress zone
Below Avwap Earnings
Tailwinds
Shakeout
C3.ai, Inc. is an enterprise artificial intelligence (AI) software provider that develops and deploys application-specific solutions across various industrial and government sectors. The company’s core offering is the C3 Agentic AI platform, which serves as an integrated development and runtime environment for building enterprise-scale AI applications. Its product portfolio includes specialized suites for customer relationship management (CRM), healthcare, financial services, supply chain optimization, and sustainability management.
The company operates within the Systems Software sub-industry, utilizing a Software-as-a-Service (SaaS) business model that prioritizes recurring subscription revenue. This model is characterized by high scalability and deep integration into client workflows, particularly through strategic cloud partnerships with Microsoft Azure, AWS, and Google Cloud. Enterprise AI adoption often requires significant computational resources and data integration capabilities to move from pilot programs to full-scale production environments.
C3.ai also provides mission-critical tools for defense, intelligence, and local government agencies, including applications for law enforcement and property appraisal. The firm’s generative AI capabilities focus on retrieving and presenting information from disparate enterprise data stores to improve decision-making. You can explore further technical analysis and valuation metrics on ValueRay to deepen your understanding of this stock. Headquartered in Redwood City, California, the company maintains alliances with major consultancy and industrial firms like McKinsey & Company and Baker Hughes to drive industry-specific AI implementation.
- Enterprise AI platform adoption drives subscription revenue
- Strategic partnerships expand market reach and sales channels
- Generative AI product suite boosts competitive positioning
- Government contract awards secure significant revenue streams
| Net Income: -470.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.23 > 0.02 and ΔFCF/TA -19.03 > 1.0 |
| NWC/Revenue: 240.3% < 20% (prev 198.5%; Δ 41.78% < -1%) |
| CFO/TA -0.23 > 3% & CFO -189.9m > Net Income -470.4m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 6.64 > 1.5 & < 3 |
| Outstanding Shares: last quarter (146.2m) vs 12m ago 9.75% < -2% |
| Gross Margin: 30.92% > 18% (prev 60.62%; Δ -29.70% > 0.5%) |
| Asset Turnover: 27.17% > 50% (prev 37.92%; Δ -10.75% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.74 (Total Current Assets 708.0m - Total Current Liabilities 106.6m) / Total Assets 816.3m |
| B: -2.27 (Retained Earnings -1.85b / Total Assets 816.3m) |
| C: -0.53 (EBIT TTM -487.7m / Avg Total Assets 921.1m) |
| D: 4.02 (Book Value of Equity 653.8m / Total Liabilities 162.5m) |
| Altman-Z'' = -1.89 = D |
| DSRI: 1.14 (Receivables 100.5m/137.2m, Revenue 250.3m/389.1m) |
| GMI: 1.96 (GM 60.62% / 30.92%) |
| AQI: 1.23 (AQ_t 0.05 / AQ_t-1 0.04) |
| SGI: 0.64 (Revenue 250.3m / 389.1m) |
| TATA: -0.34 (NI -470.4m - CFO -189.9m) / TA 816.3m) |
| Beneish M = -2.20 (Cap -4..+1) = BB |
As of June 08, 2026, the stock is trading at USD 10.43 with a total of 9,319,849 shares traded.
Over the past week, the price has changed by -3.16%,
over one month by +8.87%,
over three months by +12.51% and
over the past year by -59.67%.
C3 Ai has received a consensus analysts rating of 2.93. Therefore, it is recommended to hold AI.
- StrongBuy: 3
- Buy: 1
- Hold: 6
- Sell: 2
- StrongSell: 3
| Analysts Target Price | 8.8 | -15.4% |
P/S = 6.0551
P/B = 2.318
Revenue TTM = 250.3m USD
EBIT TTM = -487.7m USD
EBITDA TTM = -474.1m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 5.37m USD (Leases only: 5.37m)
Net Debt = -570.1m USD (calculated: Debt 5.37m - CCE 575.4m)
Enterprise Value = 945.3m USD (1.52b + Debt 5.37m - CCE 575.4m)
Interest Coverage Ratio = unknown (Ebit TTM -487.7m / Interest Expense TTM 0.0)
EV/FCF = -4.96x (Enterprise Value 945.3m / FCF TTM -190.7m)
FCF Yield = -20.17% (FCF TTM -190.7m / Enterprise Value 945.3m)
FCF Margin = -76.20% (FCF TTM -190.7m / Revenue TTM 250.3m)
Net Margin = -187.9% (Net Income TTM -470.4m / Revenue TTM 250.3m)
Gross Margin = 30.92% ((Revenue TTM 250.3m - Cost of Revenue TTM 172.9m) / Revenue TTM)
Gross Margin QoQ = 21.94% (prev 17.34%)
Tobins Q-Ratio = 1.16 (Enterprise Value 945.3m / Total Assets 816.3m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 5.37m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -385.3m (EBIT -487.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 6.64 (Total Current Assets 708.0m / Total Current Liabilities 106.6m)
Debt / Equity = 0.01 (Debt 5.37m / totalStockholderEquity, last quarter 653.8m)
Debt / EBITDA = 1.20 (negative EBITDA) (Net Debt -570.1m / EBITDA -474.1m)
Debt / FCF = 2.99 (negative FCF - burning cash) (Net Debt -570.1m / FCF TTM -190.7m)
Total Stockholder Equity = 736.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -51.07% (Net Income -470.4m / Total Assets 816.3m)
RoE = -63.91% (Net Income TTM -470.4m / Total Stockholder Equity 736.0m)
RoCE = -68.71% (EBIT -487.7m / Capital Employed (Total Assets 816.3m - Current Liab 106.6m))
RoIC = -55.26% (negative operating profit) (NOPAT -385.3m / Invested Capital 697.2m)
WACC = 12.44% (E(1.52b)/V(1.52b) * Re(12.48%) + D(5.37m)/V(1.52b) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 12.48% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 100.00 | Cagr: 8.99%
[DCF] Fair Price = unknown (Cash Flow -190.7m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.34 | # QB: 0
Revenue Correlation: 22.47 | Revenue CAGR: 3.44% | SUE: 0.12 | # QB: 0
EPS current Quarter (2026-07-31): EPS=-0.25 | Chg30d=N/A | Revisions=-20% | Analysts=14
EPS next Quarter (2026-10-31): EPS=-0.22 | Chg30d=N/A | Revisions=-6% | Analysts=14
EPS current Year (2027-04-30): EPS=-0.79 | Chg30d=N/A | Revisions=+33% | GrowthEPS=+41.6% | GrowthRev=-10.3%
EPS next Year (2028-04-30): EPS=-0.45 | Chg30d=N/A | Revisions=+27% | GrowthEPS=+42.5% | GrowthRev=+10.7%
[Analyst] Revisions Ratio: +33%